selfbnd411
Posts: 598
Joined: 7/23/2005
Status: offline
|
Talk about nasty side effects.
F.D.A. Panel Votes Against Weight-Loss Drug
By STEPHANIE SAUL
Published: June 14, 2007
A drug once viewed as a possible magic bullet against obesity was rejected today by a federal advisory panel, which cited concerns that it increases the risk of neurological and psychiatric problems, including suicide.
Although the drug is already marketed in 37 countries under the name Acomplia, it is now unlikely that the Food and Drug Administration will approve its sale in the United States. The advisory panel voted unanimously, 14 to 0, against recommending the drug, saying there was inadequate safety data to support its use.
...
The committee’s vote that there the safety data was inadequate came after Dr. Egan’s presentation, which indicated that the drug doubled a patient’s risk of psychological problems, including anxiety, depression, aggression and psychosis.
The committee also heard about data showing an increase in suicidal thinking among users of the drug, including four patients who did commit suicide while on it.
http://www.nytimes.com/2007/06/14/business/14drug-web.html?_r=1&ref=business&oref=slogin
|
FDA Rejects Obesity Drug w/ Suicidal Side Effect - 
Profile
New Messages
No New Messages
Hot Topic w/ New Messages
Hot Topic w/o New Messages
Locked w/ New Messages
Locked w/o New Messages
Post New Thread